Search

everythinglearnresearchcommunity

for

Search:↓

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Effective treatment significantly improves pododermatitis in dogs, reducing symptoms and extending remission.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Immunotherapy can help treat severe alopecia areata.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The summit aimed to speed up finding treatments for alopecia areata.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Hair follicle regeneration needs special conditions and young cells.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.